DB
BEAT

Dmitry Balyasny’s BioTelemetry, Inc. BEAT Stock Holding History

Dmitry Balyasny’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,419
Closed -$1.04M – 2265
2020
Q4 		$1.04M Sell
14,419
-161,361
-92% -$8.45M 0.01% 1007
2020
Q3 		$8.01M Buy
175,780
+161,817
+1,159% +$6.76M 0.06% 460
2020
Q2 		$631K Sell
13,963
-83,611
-86% -$3.75M 0.01% 901
2020
Q1 		$3.76M Buy
97,574
+90,575
+1,294% +$4.17M 0.04% 471
2019
Q4 		$324K Sell
6,999
-1,693
-19% -$73.3K ﹤0.01% 1052
2019
Q3 		$354K Sell
8,692
-47,875
-85% -$2.07M ﹤0.01% 998
2019
Q2 		$2.72M Buy
+56,567
New +$2.97M 0.02% 788
2019
Q1 		– Sell
-5,137
Closed -$307K – 1810
2018
Q4 		$307K Buy
+5,137
New +$308K ﹤0.01% 1223
2013
Q4 		– Sell
-998,893
Closed -$9.9M – 776
2013
Q3 		$9.9M Buy
998,893
+188,663
+23% +$1.48M 0.13% 205
2013
Q2 		$4.78M Buy
+810,230
New +$2.73M 0.08% 303

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.69B AUM 46.33% 1-Year Est. Return

Dmitry Balyasny's BEAT Position: Q1 2021 in Review

Dmitry Balyasny sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 14,419 shares — an estimated $1.04M sold.

Dmitry Balyasny first reported a position in BEAT in Q2 2013 and held it in 10 quarters. The position peaked at $9.9M in Q3 2013. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Dmitry Balyasny reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Dmitry Balyasny sold 14,419 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.04M.
  • Dmitry Balyasny first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 10 quarters.
  • Dmitry Balyasny's BioTelemetry, Inc. position peaked at $9.9M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Balyasny Asset Management's 13F filing for Q1 2021, filed 17 May 2021.